SCHEMBL8989701

SCHEMBL8989701

O=C(NCCN1CC2CC(c3ccccc3F)C2C1)c1ccc(Cl)cc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.49
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
HTR2C P28335 1/20 0.48
DRD3 P35462 1/20 0.48
HTR1A P08908 2/20 0.47
MAOA P21397 1/20 0.47
MAOB P27338 1/20 0.47
KCNH2 Q12809 1/20 0.47
CD274 Q9NZQ7 1/20 0.47
PLD1 Q13393 3/20 0.46
SIGMAR1 Q99720 2/20 0.46
TMEM97 Q5BJF2 1/20 0.46
PLD2 O14939 1/20 0.43
MAPT P10636 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
EPHX2 P34913 1/20 0.42
HTR2A P28223 1/20 0.42
SLC6A4 P31645 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7774081 0.80 ALDH1A1 (0.50) ALDH1A1HTR2CDRD3HTR1AMAOA
SCHEMBL7778725 0.80 PLD1 (0.51) ALDH1A1HTR2CDRD3HTR1ACD274
SCHEMBL8989768 0.80 ALDH1A1 (0.49) ALDH1A1HTR1AMAOAMAOBKCNH2
SCHEMBL8989765 0.79 SIGMAR1 (0.58) ALDH1A1DRD3SIGMAR1TMEM97SMN1; SMN2
SCHEMBL7071623 0.79 ALDH1A1 (0.51) ALDH1A1MEN1KMT2AHTR2CDRD3
SCHEMBL8989699 0.79 PLD1 (0.56) ALDH1A1HTR2CDRD3HTR1ACD274
SCHEMBL7778723 0.79 ALDH1A1 (0.48) ALDH1A1HTR2CDRD3HTR1AMAOA
SCHEMBL7781808 0.79 HTR2C (0.43) HTR2CDRD3HTR1APLD1HTR2A
SCHEMBL7781809 0.78 TMEM97 (0.51) ALDH1A1DRD3HTR1APLD1SIGMAR1
SCHEMBL7781108 0.77 PLD1 (0.53) HTR1ACD274PLD1PLD2EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5521209-A N-substituted azabicyclo[3.2.0]heptane derivatives as neuroleptics, the preparation and use thereof BASF AKTIENGESELLSCHAFT (DE) 1996-05-28 US claimed
EP-0646110-B1 N-SUBSTITUTED 3-AZABICYCLO[3.2.0]HEPTANE DERIVATIVES USEFUL AS NEUROLEPTIC AGENTS BASF AG (DE) 1996-10-23 EP disclosed
US-5521209-A N-substituted azabicyclo[3.2.0]heptane derivatives as neuroleptics, the preparation and use thereof BASF AKTIENGESELLSCHAFT (DE) 1996-05-28 US disclosed
EP-0646110-A1 N-SUBSTITUED 3-AZABICYCLO 3.2.0]HEPTANE DERIVATIVES USEFUL AS NEUROLEPTIC AGENTS ETC. BASF AG (DE) 1995-04-05 EP disclosed
WO-1994000431-A1 N-SUBSTITUED 3-AZABICYCLO[3.2.0]HEPTANE DERIVATIVES USEFUL AS NEUROLEPTIC AGENTS ETC. BASF AKTIENGESELLSCHAFT (DE) 1994-01-06 WO disclosed